Xencor Inc (XNCR): EPS (Basic)
-$1.24
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$1.24 | n/m | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | -$3.58 | n/m | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | -$2.20 | n/m | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | -$0.93 | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $1.42 | n/m | 2025-02-24, From 2021-01-01 |
| 2020-12-31 | -$1.21 | n/m | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $0.48 | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$1.31 | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | -$0.82 | n/m | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $1.09 | n/c | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$0.45 | n/m | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | -$0.52 | n/m | 2017-03-01, From 2014-01-01 |
| 2013-12-31 | $34.18 | n/m | 2016-03-08, From 2013-01-01 |
| 2012-12-31 | -$118.86 | n/a | 2015-02-23, From 2012-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Xencor Inc (XNCR) | 2025-12-31 | -$1.24 | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$1.27 | n/m |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $0.06 | -57.1% |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | -$3.19 | n/m |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$17.93 | n/m |
| Theravance Biopharma, Inc. (TBPH) | 2025-12-31 | $2.10 | n/m |
| Zevra Therapeutics, Inc. (ZVRA) | 2025-12-31 | $1.40 | n/m |
| Zymeworks Inc. (ZYME) | 2025-12-31 | -$1.08 | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $0.04 | n/a |
Compare XNCR, LFCR, GYRE, URGN side by side · Screen every company in Pharmaceutical Preparations ↗